Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain

被引:17
作者
Spiliotopoulos, Dimitrios [1 ]
Zhu, Jian [1 ]
Wamhoff, Eike-Christian [2 ,3 ]
Deerain, Nicholas [1 ]
Marchand, Jean-Remy [1 ]
Aretz, Jonas [2 ,3 ]
Rademacher, Christoph [2 ,3 ]
Caflisch, Amedeo [1 ]
机构
[1] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Muhlenberg 1, D-14424 Potsdam, Germany
[3] Free Univ Berlin, Dept Biol Chem & Pharm, Inst Med & Biochem, Takustr 3, D-14195 Berlin, Germany
基金
瑞士国家科学基金会;
关键词
Docking; Virtual screening; NMR spectroscopy; Epigenetics; X-ray crystallography; Bromodomain inhibitors; BINDING; INHIBITORS; LIGANDS; DOCKING; POTENT; BRD4; IDENTIFICATION; OPTIMIZATION; DESIGN;
D O I
10.1016/j.bmcl.2017.04.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Overexpression of the CREB-binding protein (CBP), a bromodomain-containing transcription coactivator involved in a variety of cellular processes, has been observed in several types of cancer with a correlation to aggressiveness. We have screened a library of nearly 1500 fragments by high-throughput docking into the CBP bromodomain followed by binding energy evaluation using a force field with electrostatic solvation. Twenty of the 39 fragments selected by virtual screening are positive in one or more ligand-observed nuclear magnetic resonance (NMR) experiments. Four crystal structures of the CBP bromodomain in complex with in silico screening hits validate the pose predicted by docking. Thus, the success ratio of the high-throughput docking procedure is 50% or 10% if one considers the validation by ligand-observed NMR spectroscopy or X-ray crystallography, respectively. Compounds 1 and 3 show favorable ligand efficiency in two different in vitro binding assays. The structure of the CBP bromodomain in the complex with the brominated pyrrole 1 suggests fragment growing by Suzuki coupling. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2472 / 2478
页数:7
相关论文
共 50 条
  • [21] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Namanja, Andrew T.
    Xu, Jia
    Wu, Haihong
    Sun, Qi
    Upadhyay, Anup K.
    Sun, Chaohong
    Van Doren, Steven R.
    Petros, Andrew M.
    JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (12) : 675 - 685
  • [22] Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
    Li, Qingxin
    Kang, Congbao
    MOLECULES, 2024, 29 (23):
  • [23] Fragment-Based Drug Discovery for Trypanosoma brucei Glycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR Methods
    Ibrahim, Mohammed Auwal
    Yamasaki, Tomoko
    Furukawa, Koji
    Yamasaki, Kazuhiko
    JOURNAL OF BIOCHEMISTRY, 2022, 171 (06) : 619 - 629
  • [24] A Multi-Step NMR Screen for the Identification and Evaluation of Chemical Leads for Drug Discovery
    Mercier, Kelly A.
    Shortridge, Matthew D.
    Powers, Robert
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (03) : 285 - 295
  • [25] A Benchmark Study of Protein-Fragment Complex Structure Calculations with NMR2
    Torres, Felix
    Stadler, Gabriela
    Kwiatkowski, Witek
    Orts, Julien
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [26] Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
    Mureddu, Luca G.
    Vuister, Geerten W.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [27] Discovery of Chemokine CXCL12 Inhibitors by Tandem Application of Virtual Screening and NMR Spectrometry
    Zhou, Jiao
    Li, Wei
    Guan, Shanyue
    Chen, Xiaohong
    Liu, Xiang
    Shao, Weiyan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (22) : 5729 - 5737
  • [28] Using NMR Spectroscopy in the Fragment-Based Drug Discovery of Small-Molecule Anticancer Targeted Therapies
    Diethelm-Varela, Benjamin
    CHEMMEDCHEM, 2021, 16 (05) : 725 - 742
  • [29] Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
    Yao, Dahong
    Zhang, Jin
    Wang, Jinhui
    Pan, Dabo
    He, Zhendan
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 713 - 725
  • [30] Discovery of Highly Potent Microsomal Prostaglandin E2 Synthase 1 Inhibitors Using the Active Conformation Structural Model and Virtual Screen
    He, Shan
    Li, Cong
    Liu, Ying
    Lai, Luhua
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (08) : 3296 - 3309